Local Leukocyte Invasion during Hyperacute Human Ischemic Stroke.
Alexander M Kollikowski, Michael K Schuhmann, Bernhard Nieswandt...
https://pubmed.ncbi.nlm.nih.gov/31899551/Actively Recruiting
Led by First Affiliated Hospital of Wannan Medical College · Updated on 2025-05-11
500
Participants Needed
5
Research Sites
N/A
Total Duration
Researchers are conducting a multicenter, ambispective cohort study to collect and analyze samples and data from patients with acute ischemic stroke caused by large vessel occlusion AIS-LVO. The study aims to build a comprehensive biobank including thrombi, intracranial blood, peripheral arterial and venous blood, along with clinical, laboratory, imaging, and follow-up information. This will help explore differences in blood samples and develop a detailed multiomics profile related to stroke. Samples such as blood clots and blood from different sites undergo pathological, metabolomic, proteomic, and genomic tests for multidimensional analysis. The study collects data from five stroke centers and includes pathological and histological examination of thrombus samples for some patients. Researchers plan to use these findings to identify stroke causes, therapeutic targets, risk factors, and prognosis by creating prediction models based on the combined multiomics data. Participants provide clinical and biological samples, and their health status is monitored through clinical and imaging evaluations over time. The primary outcome measured is the number of patients experiencing futile recanalization from enrollment to three months follow-up. Secondary outcomes include stroke causes, hemorrhagic transformation within seven days, and infarct expansion at baseline. The study is observational and involves no experimental treatments, focusing on data and sample collection to advance stroke research.
CONDITIONS
Cerebral Large Vessel Occlusion Stroke Multiomics Biosample Cohort
Z
Zhiyuan Feng, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
First Affiliated Hospital of Wannan Medical College
Lead Sponsor
Beijing Tiantan Hospital
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - At baseline
Participants provide blood clot, peripheral arterial and venous blood, and intracranial blood samples for multi-omics analysis and pathological examination.
1 visit (in-person)
Duration - Up to 3 months
Participants' clinical, laboratory, imaging, and follow-up data are collected to support analysis of stroke outcomes and multi-omics profiles.
Follow-up visits up to 3 months
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Alexander M Kollikowski, Michael K Schuhmann, Bernhard Nieswandt...
https://pubmed.ncbi.nlm.nih.gov/31899551/S Staessens, S Fitzgerald, T Andersson...
https://pubmed.ncbi.nlm.nih.gov/31679478/Marc Strinitz, Mirko Pham, Alexander G März...
https://pubmed.ncbi.nlm.nih.gov/34502070/Xin Xu, Yiming Song, Wenbo Cao...
https://pubmed.ncbi.nlm.nih.gov/38293908/Zhiyuan Feng, Ming Yang, Jing Xue...
https://pubmed.ncbi.nlm.nih.gov/42567544/Guido Stoll, Michael K Schuhmann, Bernhard Nieswandt...
https://pubmed.ncbi.nlm.nih.gov/35676801/Smita Patil, Jean Darcourt, Pierluca Messina...
https://pubmed.ncbi.nlm.nih.gov/35241632/Lena Zimmermann, Mirko Pham, Alexander G März...
https://pubmed.ncbi.nlm.nih.gov/35107055/Senna Staessens, Olivier François, Waleed Brinjikji...
https://pubmed.ncbi.nlm.nih.gov/34517770/Cyril Dargazanli, Marine Blaquière, Marinette Moynier...
https://pubmed.ncbi.nlm.nih.gov/38514190/First Affiliated Hospital of Wannan Medical College
Lead Sponsor
Beijing Tiantan Hospital
Collaborating Sponsor